TELCON RF PHARMACEUTICAL. Inc. (200230.KQ) KOE
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In KRW
| Market Cap | 62.83B |
| Enterprise Value | 70.98B |
| P/E Ratio | -0.12 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0.06 |
| Price/Book Ratio | 0.03 |
| Enterprise/Revenue | 0.8 |
| Enterprise/EBITDA | 2.49 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.19 |
| Operating Margin | 0.02 |
| Return On Assets | -0.06 |
| Return On Equity | -0.09 |
| Revenue | 43.16B |
| Revenue/Share | 6,258.22 |
| Gross Profit | 7.32B |
| EBITDA | 5.54B |
| Net Income | -11.46B |
| Diluted EPS | -1,707.7 |
| Total Cash | 33.94B |
| Total Cash/Share | 4,954.06 |
| Total Debt | 39.82B |
| Total Debt/Equity | 0.41 |
| Current Ratio | 1.24 |
| Book Value Per Share | 14,219.46 |
| 52-Week Change | -97.17 |
| 52-Week High | 44,050 |
| 52-Week Low | 325 |
| Moving Average 50 Days | 6,307.6 |
| Moving Average 200 Days | 9,741.2 |
| Average Volume | 113,858 |
| Shares Outstanding | 7.15M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | June 04, 2026 |